歐洲放射腫瘤學市場預測至 2031 年 - 區域分析 - 按類型和應用
市場調查報告書
商品編碼
1637689

歐洲放射腫瘤學市場預測至 2031 年 - 區域分析 - 按類型和應用

Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日期: | 出版商: The Insight Partners | 英文 87 Pages | 訂單完成後即時交付

價格

2023年歐洲放射腫瘤市值為33.1721億美元,預計2031年將達到87.2307億美元;預計2023年至2031年複合年成長率為12.8%。

支持放射腫瘤學發展的措施推動歐洲放射腫瘤學市場

各國政府和組織正在引入利用放射療法快速有效治療癌症的使命和計劃。 2023年9月,國際原子能總署(IAEA)宣布了「希望之光」旗艦癌症計劃,旨在發展放射治療基礎設施。在美國、德國、英國、法國等已開發國家,幾乎所有患者都能接受放射治療。在中等收入國家,60% 的患者群體和低收入國家十分之一的患者能夠接受放射治療。 「人人享有希望之光癌症照護」重點關注全世界放射治療服務的發展。自該計劃啟動以來,各國都收到了放射治療設備以及操作設備以進行及時診斷和治療所需的培訓。五大洲都參與了該計劃,並為該計劃捐款 4,550 萬美元(4,200 萬歐元),私營部門投資了 768,902 美元(710,000 歐元)提供支持。此外,醫科達等製造商與國際原子能機構簽署了合作夥伴關係,透過在世界各地提供放射治療設備來改善癌症治療。此外,原子能機構開始培訓不同領域的醫療保健專業人員,其中包括14名放射腫瘤學家、13名醫學物理學家、4名核子醫學技術專家、7名核子醫學醫師、7名放射性藥劑師、16名放射治療技術專家、7名腫瘤護理師、4名醫學影像技術專家和7名放射科醫師。因此,放射治療措施的激增預計將提高低收入國家的滲透率,加上訓練有素的專業人員和放射治療基礎設施的發展正在推動未來幾年放射腫瘤學市場的成長。

歐洲放射腫瘤學市場概況

德國擁有先進的醫療基礎設施,可以使用支援放射治療程序實施的尖端技術。該國也以其對創新和研究的高度重視而聞名。在德國營運的綜合癌症中心提供多學科治療計劃,包括放射治療、手術、化療和其他醫療程序。 2020 年,瓦里安宣布位於海德堡的德國癌症研究中心 (DKFZ) 訂購了自適應智慧解決方案,這是該國首個 Ethos 療法。這種由人工智慧驅動的全方位解決方案旨在提高放射治療的療效、適應性和能力。

歐洲放射腫瘤學市場收入及 2031 年預測(百萬美元)

歐洲放射腫瘤學市場細分

歐洲放射腫瘤學市場按類型、應用和國家分類。

根據類型,歐洲放射腫瘤學市場分為體外放射治療和內照射放射治療。 2023 年,體外放射治療領域將佔據更大的市場佔有率。

從應用來看,歐洲放射腫瘤市場分為乳癌、攝護腺癌、肺癌、頭頸癌、子宮頸癌等。 2023 年,乳癌細分市場佔據最大的市場佔有率。

依國家/地區分類,歐洲放射腫瘤市場分為德國、英國、法國、西班牙、義大利和歐洲其他地區。 2023 年,德國在歐洲放射腫瘤市場佔有率中佔據主導地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc 和 Curium 是歐洲輻射領域的一些領先公司腫瘤學市場。

目錄

第 1 章:簡介

第 2 章:執行摘要

  • 主要見解

第 3 章:研究方法

  • 二次研究
  • 初步研究
    • 假設表述:
    • 宏觀經濟因素分析:
    • 顯影基數:
    • 數據三角測量:
    • 國家級資料:

第 4 章:歐洲放射腫瘤學市場 - 主要市場動態

  • 市場促進因素:
    • 癌症盛行率增加
    • 支持放射腫瘤學發展的舉措
  • 市場限制
    • 放射治療設備成本高
  • 市場機會
    • 放射腫瘤學策略舉措
  • 未來趨勢
    • 放射腫瘤學的技術進步
  • 促進因素和限制的影響:

第 5 章:放射腫瘤學市場 - 歐洲市場分析

  • 放射腫瘤學市場收入,2021-2031

第 6 章:歐洲放射腫瘤學市場分析 - 按類型

  • 外束放射治療
  • 內束放射治療

第 7 章:歐洲放射腫瘤學市場分析 - 按應用

  • 乳癌
  • 攝護腺癌
  • 肺癌
  • 頭頸癌
  • 子宮頸癌
  • 其他

第 8 章:歐洲放射腫瘤學市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區

第 9 章:放射腫瘤學市場 - 產業格局

  • 概述
  • 放射腫瘤學市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 10 章:公司簡介

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Nordion
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Curium

第 11 章:附錄

Product Code: BMIRE00030997

The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.

Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market

The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the "Rays of Hope"-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The "Rays of Hope Cancer Care for All" focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.

Europe Radiation Oncology Market Overview

Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.

Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Europe Radiation Oncology Market Segmentation

The Europe radiation oncology market is categorized into types, application, and country.

Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Radiation Oncology Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Increasing Prevalence of Cancer
    • 4.1.2 Initiatives to Support Developments in Radiation Oncology
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Radiotherapy Equipment
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives in Radiation Oncology
  • 4.4 Future Trends
    • 4.4.1 Technological Advancement in Radiation Oncology
  • 4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Europe Market Analysis

  • 5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Europe Radiation Oncology Market Analysis - by Types

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Overview
    • 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Overview
    • 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Radiation Oncology Market Analysis - by Application

  • 7.1 Breast Cancer
    • 7.1.1 Overview
    • 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Prostate Cancer
    • 7.2.1 Overview
    • 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Lung Cancer
    • 7.3.1 Overview
    • 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Head and Neck Cancer
    • 7.4.1 Overview
    • 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Cervical Cancer
    • 7.5.1 Overview
    • 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Radiation Oncology Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.1.1 Germany: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.1.4 Germany: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.3.1 France: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.3.4 France: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Spain: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.4.4 Spain: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.5.1 Italy: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.5.4 Italy: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Radiation Oncology Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Varian Medical Systems Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview (Siemens Healthineers AG)
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elekta AB
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Accuray Incorporated
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 IBA Worldwide (Ion Beam Applications SA)
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Becton Dickinson and Co
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Nordion
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Mevion Medical Systems
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 NTP RADIOISOTOPES
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Mallinckrodt Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Curium
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Radiation Oncology Market Segmentation
  • Table 2. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 28. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Europe Radiation Oncology Market Segmentation, by Country
  • Figure 2. Radiation Oncology Market - Key Market Dynamics
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Europe Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 17. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Growth Strategies in Radiation Oncology Market